Larvol Delta - Codiak-Reports-Positive-Initial-Data-for-exoSTING-Phase-12-Trial-Indicating-Tolerability-Immune-Activation-and-Evidence-of-Tumor-Shrinkage-in-Injected-and-NonInjected-Tumors-in-the-First-Three-Dose-Escalation-Cohorts

exoSTING - Codiak

https://www.globenewswire.com/news-release/2021/11/16/2335127/0/en/Codiak-Reports-Positive-Initial-Data-for-exoSTING-Phase-1-2-Trial-Indicating-Tolerability-Immune-Activation-and-Evidence-of-Tumor-Shrinkage-in-Injected-and-Non-Injected-Tumors-in-t.html

Nov 16, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next